Duodenal biopsy may be avoided when high transglutaminase antibody titers are present

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 38

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

368

HTML

2846

Figures (1-5)

Tables (1-1)

Sum=3214

Oct 14, 2009 (publication date) through Nov 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Gastroenterol. Oct 14, 2009; 15(38): 4775-4780
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4775

Full Size Figure Download Figure

Figure 5 Follow-up of adult patients with an initial Marsh type 3 biopsy. Repeated biopsy showed persistent atrophy in 25% of the cases.

Citation: Vivas S, Ruiz de Morales JG, Riestra S, Arias L, Fuentes D, Alvarez N, Calleja S, Hernando M, Herrero B, Casqueiro J, Rodrigo L. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol 2009; 15(38): 4775-4780
URL: https://www.wjgnet.com/1007-9327/full/v15/i38/4775.htm
DOI: https://dx.doi.org/10.3748/wjg.15.4775